KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Inventory: 2009-2025

Historic Inventory for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $3.3 billion.

  • Teva Pharmaceutical Industries' Inventory fell 16.06% to $3.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 billion, marking a year-over-year decrease of 16.06%. This contributed to the annual value of $3.0 billion for FY2024, which is 25.22% down from last year.
  • As of Q3 2025, Teva Pharmaceutical Industries' Inventory stood at $3.3 billion, which was down 4.98% from $3.5 billion recorded in Q2 2025.
  • Teva Pharmaceutical Industries' Inventory's 5-year high stood at $4.4 billion during Q1 2021, with a 5-year trough of $3.0 billion in Q4 2024.
  • In the last 3 years, Teva Pharmaceutical Industries' Inventory had a median value of $3.9 billion in 2024 and averaged $3.7 billion.
  • In the last 5 years, Teva Pharmaceutical Industries' Inventory grew by 4.98% in 2023 and then decreased by 25.22% in 2024.
  • Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Inventory stood at $3.8 billion in 2021, then grew by 0.39% to $3.8 billion in 2022, then increased by 4.90% to $4.0 billion in 2023, then dropped by 25.22% to $3.0 billion in 2024, then fell by 16.06% to $3.3 billion in 2025.
  • Its Inventory stands at $3.3 billion for Q3 2025, versus $3.5 billion for Q2 2025 and $3.2 billion for Q1 2025.